Celltrion Healthcare Co.
Scope
Date
~
-
Healthcare
KT expands healthcare business in Vietnam
South Korea’s telecom service provider KT Corp. has recently organized a collaborative seminar on digital health alongside Hanoi Medical Unive...
Jul 12, 2023 (Gmt+09:00)
-
Carbon neutrality
Samsung Biologics, Celltrion pledge major CO2 cuts
South Korea’s No. 1 biopharmaceutical company Samsung BioLogics Co. and No. 2 Celltrion Inc. produced higher CO2 emissions last year than in 2...
Jul 10, 2023 (Gmt+09:00)
-
Venture capital
Ontario, S.Korea VC firm to establish $76 mn healthcare fund
Canada's Ontario government has joined hands with a South Korean venture capital firm to establish a fund of 100 million Canadian dollars ($75.6 mil...
Jul 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches Humira biosimilar Yuflyma in US
South Korean biopharmaceutical company Celltrion Healthcare on Monday said it launched the day before on the US market Yuflyma, a biosimilar of the ...
Jul 04, 2023 (Gmt+09:00)
-
Pension funds
NPS taps Macquarie, IMM, Hahn & Co. as private equity managers
The National Pension Service (NPS) of South Korea, the world’s third-largest pension fund, said on Friday it has hired Macquarie Asset Managem...
Jun 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in US for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. on Friday said it applied for approval from the US Food and Drug Administration (FDA) for CT-P...
Jun 30, 2023 (Gmt+09:00)
-
Metaverse
Kakao Healthcare to build metaverse healthcare platform
Kakao Healthcare, a digital healthcare platform unit of South Korea's Kakao, announced on Wednesday that it has been selected as the final operato...
Jun 28, 2023 (Gmt+09:00)
-
Machinery
HD Hyundai Infracore targets eco-friendly equipment market
HD Hyundai Infracore Co., a construction equipment unit of South Korea’s HD Hyundai Group, is set to make inroads into the eco-friendly sector...
Jun 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Kakao Healthcare ties up with Dexcom for global diabetes biz
South Korea’s Kakao Healthcare Corp. has taken a step forward to expand its business into the global market by collaborating with US medical d...
Jun 22, 2023 (Gmt+09:00)
-
Get It Made in Korea
Dong-A ENG Co.
Key facts Industry Mass-production mold design and manufacturing/machinery manufacturing Mainstay products/services Automotive int...
Jun 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion puts Takeda’s assets up for sale after 3 years
South Korea’s Celltrion Inc. has put its Japanese Takeda Pharmaceutical Co.'s primary care assets acquired in 2020 on sale as the biosimilar g...
Jun 18, 2023 (Gmt+09:00)
-
Dong-A ENG Co.
Key facts Industry Mass-production mold design and manufacturing/machinery manufacturing Mainstay products/services Automotive interior ...
Jun 16, 2023 (Gmt+09:00)
-
QNES Global Co.
Key facts Industry Injection molding Mainstay products/services Micro injection molding, on-demand product/mold development to productio...
Jun 16, 2023 (Gmt+09:00)
-
RheeTech Co.
Key facts Industry Mold design and production, injection molding Mainstay products/services Mass-production molds for PTFE and PEEK mate...
Jun 16, 2023 (Gmt+09:00)
-
Min Sung Precision Co.
Key facts Industry Industrial mold manufacturing and repairment/plastic injection molding Mainstay products/services High-precision mold...
Jun 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm’s Cenobamate gets nod in Canada, to boost US sales
South Korea’s SK Biopharmaceuticals Co. has obtained the sales approval for its antiepileptic treatment Cenobamate in Canada, paving the way f...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins phase 3 IND approval for Ocrevus biosimilar in US
South Korea's biopharmaceutical company Celltrion Inc. announced that it received on Thursday approval from the US Food and Drug Administration (FDA...
Jun 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand biosimilar portfolio to 11 by 2025
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...
Jun 13, 2023 (Gmt+09:00)
-
CAPA: Dong-A ENG Co.
Key facts:- Industry: Mass-production mold design and manufacturing/machinery manufacturing- Mainstay products/services: Automotive interior molds, GM...
Jun 07, 2023 (Gmt+09:00)
-
Dong-A Eng Co.
Key facts Main Business Industrial mold design and manufacturing / machinery manufacturing212.1 Millions USE(Automated Optical Inspection; AOI...
Jun 06, 2023 (Gmt+09:00)
-
Healthcare
S.Korea to seek expansion of healthcare package export
South Korean government has set a goal to expand medical service exports by attracting 700,000 foreign patients and receiving 70 applications of ove...
Jun 05, 2023 (Gmt+09:00)
-
Korean startups
Bredis Healthcare, Tilda win June D.Day, Korea’s oldest startup pitch race
An early-stage startup by young entrepreneurs who developed a digital diagnostic tool for brain disease and an AI-powered business optimization prog...
Jun 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to develop Humira biosimilar oral medication with US firm
South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...
Jun 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima SC praised in Europe as preferred biosimilar
MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...
Jun 02, 2023 (Gmt+09:00)
-
Real estate
Germany's real estate mezzanine market to shine in 2023: Lenwood Capital
The global real estate market is under significant pressure due to increased interest rates and banks' tighter loan standards in 2023. Commercial re...
Jun 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe
South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
BIO USA 2023 to draw S.Korean biotech leaders, startups
More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...
May 30, 2023 (Gmt+09:00)
-
Private equity
MBK co-founder meets with Korean CIOs to finance 6th buyout fund
Asia’s private equity giant MBK Partners Ltd. is set to accelerate fundraising for its new fund, which is expected to become the firm’s ...
May 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
-
Bio & Pharma
CrystalGenomics to sell largest 20% stake to Invites Healthcare for $44 mn
CrystalGenomics Inc., South Korea’s first-generation biopharma venture company, will sell new shares worth 58 billion won ($44 million) in a b...
May 23, 2023 (Gmt+09:00)
Latest News
- 1 BMW surpasses Mercedes in Korean sales amid imported car market shake-up
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google